Developer of a clinical-stage biotechnology company designed to pioneer precision medicines for brain diseases through the integration of data science and neuroscience. The company offers a precision neuroscience platform that cuts through brain disease heterogeneity to match the right patient populations to targeted therapeutics.
Currently, there are no issues on this topic.